ArticleClinical rheumatology2007

T-889C IL-1alpha promoter polymorphism influences the response to oral cyclophosphamide in scleroderma patients with alveolitis.

Lorenzo Beretta et al.PubMed ↗Publisher ↗

No numbers read from the abstract.